Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DY.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.49ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.49NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used